These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 19438776)

  • 21. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution.
    Kalya AV; Tector AJ; Crouch JD; Downey FX; McDonald ML; Anderson AJ; Bartoszewski CJ; Hosenpud JD
    J Heart Lung Transplant; 2005 Nov; 24(11):1973-5. PubMed ID: 16297807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
    Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical circulatory support as a bridge to transplant candidacy.
    Elhenawy AM; Algarni KD; Rodger M; Maciver J; Maganti M; Cusimano RJ; Yau TM; Delgado DH; Ross HJ; Rao V
    J Card Surg; 2011 Sep; 26(5):542-7. PubMed ID: 21883463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada.
    Carrier M; Perrault LP; Bouchard D; Pellerin M; Racine N; White M; Pelletier G
    Can J Cardiol; 2004 Apr; 20(5):501-4. PubMed ID: 15100751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of left ventricular assist device infection on post-transplant outcomes.
    Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
    J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience.
    Morgan JA; John R; Rao V; Weinberg AD; Lee BJ; Mazzeo PA; Flannery MR; Chen JM; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1309-16. PubMed ID: 15115987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
    Drakos SG; Stringham JC; Long JW; Gilbert EM; Fuller TC; Campbell BK; Horne BD; Hagan ME; Nelson KE; Lindblom JM; Meldrum PA; Carlson JF; Moore SA; Kfoury AG; Renlund DG
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1612-9. PubMed ID: 17532964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
    Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
    J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
    George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.